Thrombocytopenia Clinical Trial
— UNITOfficial title:
IMMUNE-GENETIC ASSESSMENT OF PRIMARY ITP IN ADULT
| NCT number | NCT01196884 |
| Other study ID # | UNIT |
| Secondary ID | |
| Status | Unknown status |
| Phase | |
| First received | September 7, 2010 |
| Last updated | March 19, 2018 |
| Start date | September 2010 |
Primary ITP has wide heterogenous biology, presentation and response to therapy.
The immune-genetic assessment of ITP may help to identify differences among patients with ITP
and optimize the therapeutic choice.
| Status | Unknown status |
| Enrollment | 190 |
| Est. completion date | |
| Est. primary completion date | |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Adult patients with primary ITP Exclusion Criteria: - Secondary ITP |
| Country | Name | City | State |
|---|---|---|---|
| Italy | Istituto di Ematologia L. & A. Seragnoli | Bologna | |
| Italy | Department of Hematology and Bone Marrow Transplantation Unit, Oncology Center Armando Businco | Cagliari | |
| Italy | UF Ematologia, Policlinico di Careggi | Firenze | |
| Italy | Department of Oncology/Haematology, Niguarda Ca'Granda Hospital | Milano | |
| Italy | U.O. Ematologia 2, IRCCS Cà Granda Ospedale Maggiore Policlinico | Milano | |
| Italy | Clinica Ematologica, Dipartimento di Medicina Clinica e Sperimentale, Università degli Studi del Piemonte Orientale "Amedeo Avogadro | Novara | |
| Italy | Istituto di Immunologia, Dipartimento di Scienze Mediche dell'Università degli Studi del Piemonte Orientale "Amedeo Avogadro" | Novara | |
| Italy | Department of Medical and Surgical Sciences, University of Padova | Padova | |
| Italy | Oncology-Hematology Department, "S. Maria delle Croci" Hospital | Ravenna | |
| Italy | Institute of Hematology, Catholic University, | Roma | |
| Italy | Ematologia, Ospedale Ca' Foncello | Treviso | |
| Italy | Clinica Ematologica AOUD S. Maria Misericordia | Udine | |
| Italy | Ematologia, San Bortolo Hospital | Vicenza |
| Lead Sponsor | Collaborator |
|---|---|
| Azienda Sanitaria-Universitaria Integrata di Udine |
Italy,
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04003220 -
Idiopathic Chronic Thrombocytopenia of Undetermined Significance : Pathogenesis and Biomarker
|
||
| Completed |
NCT02948283 -
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
|
Phase 1 | |
| Recruiting |
NCT03633019 -
High-dose Use of rhTPO in CIT Patients
|
Phase 4 | |
| Recruiting |
NCT06087198 -
Clinical Performance Evaluation of T-TAS®01 HD Chip
|
||
| Recruiting |
NCT03605511 -
TTP and aHUS in Complicated Pregnancies
|
||
| Active, not recruiting |
NCT03688191 -
Study of Sirolimus in CTD-TP in China
|
Phase 4 | |
| Completed |
NCT02845609 -
Efficacy of Sialic Acid GNE Related Thrombocytopenia
|
Phase 2 | |
| Recruiting |
NCT02241031 -
Megakaryocytic Progenitor Cells for Prophylaxis and Treatment of Thrombocytopenia
|
Phase 2/Phase 3 | |
| Recruiting |
NCT02244658 -
Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic Leukemia
|
Phase 3 | |
| Completed |
NCT01356576 -
Effect of Hemodialysis Membranes on Platelet Count
|
N/A | |
| Terminated |
NCT01368211 -
Mirasol-Treated Platelets - (Pathogen Reduction Extended Storage Study)
|
Phase 2/Phase 3 | |
| Completed |
NCT00039858 -
Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin
|
Phase 4 | |
| Completed |
NCT00787241 -
Platelet Count Trends in Pre-eclamptic Parturients
|
N/A | |
| Completed |
NCT00001533 -
Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine
|
Phase 1 | |
| Not yet recruiting |
NCT06036966 -
The Efficacy and Safety of Hetrombopag in Primary Prevention of Thrombocytopenia Induced by the Niraparib Maintenance in Advanced Ovarian Cancer Patients
|
Phase 2 | |
| Completed |
NCT01791101 -
Eltrombopag in Patients With Delayed Post Transplant Thrombocytopenia.
|
Phase 2 | |
| Recruiting |
NCT06053021 -
Antiplatelet Therapy for AIS Patients With Thrombocytopenia
|
N/A | |
| Recruiting |
NCT03701217 -
Eltrombopag Used in Thrombocytopenia After Comsolidation Therapy in AML
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT05958511 -
Assessment of Risk Factors and Outcome of Thrombocytopenia in ICU Patients
|
||
| Completed |
NCT04917679 -
Eltrombopag Plus Diacerein vs Eltrombopag in Adult ITP
|
Phase 2 |